Eric Karas
Chief Commercial Officer · 1 filing · Latest: Jun 12, 2026
ARS Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
SPRY | Eric Karas | Chief Commercial Officer | Jun 12, 2026 | Sale | $10.00 | 25,000 | $250.0K | 12,176 | |
SPRY | Eric Karas | Chief Commercial Officer | Jun 12, 2026 | Option Exercise | $1.50 | 25,000 | $37.5K | 37,176 | |